# A Study to Evaluate the Pharmacokinetics of BMS-986141 in Participants With Hepatic Impairment Compared to Healthy Participants

> **NCT02985632** · PHASE1 · WITHDRAWN · sponsor: **Bristol-Myers Squibb**

## Conditions studied

- Hepatic Impairment

## Interventions

- **DRUG:** BMS-986141

## Key facts

- **NCT ID:** NCT02985632
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2017-01-11
- **Primary completion:** 2017-05-18
- **Final completion:** 2017-07-07
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Business objectives have changed.
- **Last updated:** 2017-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02985632

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02985632, "A Study to Evaluate the Pharmacokinetics of BMS-986141 in Participants With Hepatic Impairment Compared to Healthy Participants". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02985632. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*